Vivek Jayaraman - TriVascular Technologies Vice President - Global Sales and Marketing

President

Mr. Vivek K. Jayaraman is Vice President Global Sales and Marketing of TriVascular Technologies Inc. Mr. Jayaraman previously served in various roles of increasing responsibility at Medtronic Inc. from 2001 to 2009 most recently as the Vice President of Global MarketingEndovascular Innovations. Previously Mr. Jayaraman led Medtronics Peripheral Vascular business worked as a Policy Fellow in Medtronics Government Affairs Office in Washington D.C. and served as an expatriate in Hong Kong and Tokyo in a sales leadership role. Mr. Jayaraman also worked at the Johnson Johnson Development Corporation and began his career at The Wilkerson Group a healthcare focused management consultancy since 2009.
Age 39
Tenure 15 years
Professional MarksMBA
Phone707-543-8800
Webhttp://www.trivascular.com
Jayaraman received his M.B.A. in Health Care Management from The Wharton School at The University of Pennsylvania and his dual B.S. degree in Biology and History from the University of Michigan.

TriVascular Technologies Management Efficiency

The company has return on total asset (ROA) of (0.574) % which means that it has lost $0.574 on every $100 spent on assets. This is way below average. TriVascular Technologies' management efficiency ratios could be used to measure how well TriVascular Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 55 M in liabilities with Debt to Equity (D/E) ratio of 1.74, which is about average as compared to similar companies. TriVascular Technologies has a current ratio of 6.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist TriVascular Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, TriVascular Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TriVascular Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TriVascular to invest in growth at high rates of return. When we think about TriVascular Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Primit ParikhTransphorm Technology
52
Chuck KostalnickArrow Electronics
55
Vincent MelvinArrow Electronics
60
Charles KostalnickArrow Electronics
49
Brian CampbellEvertz Technologies Limited
61
Matt AndersonArrow Electronics
39
Lily HughesArrow Electronics
55
Andy KingArrow Electronics
55
David GranvilleSmithSphere Entertainment Co
57
Andrew KingArrow Electronics
52
Mark TaylorArrow Electronics
N/A
Andrea GreenbergSphere Entertainment Co
65
Mary MorrisArrow Electronics
61
Christopher StansburyArrow Electronics
55
Sean KerinsArrow Electronics
61
Gregory TarpinianArrow Electronics
55
TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms . TriVascular Technologies (TRIV) is traded on NASDAQ Exchange in USA and employs 307 people.

Management Performance

TriVascular Technologies Leadership Team

Elected by the shareholders, the TriVascular Technologies' board of directors comprises two types of representatives: TriVascular Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TriVascular. The board's role is to monitor TriVascular Technologies' management team and ensure that shareholders' interests are well served. TriVascular Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TriVascular Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jake Nunn, Independent Director
Christopher Chavez, Chairman, CEO and Pres
Ryan Drant, Independent Director
Michael Kramer, CFO and Principal Accounting Officer
Kimberley Elting, Chief Compliance Officer, VP of Corporate Affairs, General Counsel and Secretary
Daniel Moore, Independent Director
James Scopa, Independent Director
Vivek Jayaraman, Vice President - Global Sales and Marketing
Louis Molinari, Vice President - Manufacturing Operations
Robert Whirley, Co-Founder and VP of RandD
Robert Thomas, Independent Director
Michael Chobotov, Co-Founder and CTO
Douglas Roeder, Independent Director
Shari OQuinn, Vice President - Clinical/Regulatory Affairs and Quality

TriVascular Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TriVascular Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TriVascular Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TriVascular Technologies' short interest history, or implied volatility extrapolated from TriVascular Technologies options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in TriVascular Stock

If you are still planning to invest in TriVascular Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TriVascular Technologies' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity